Related references
Note: Only part of the references are listed.Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection
Yi-Cheng Chen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
Jerzy Jaroszewicz et al.
ANTIVIRAL THERAPY (2011)
Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum
Karsten Wursthorn et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Viral Determinants of Hepatitis B Surface Antigen Seroclearance in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients
Henry Lik-Yuen Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B
James Fung et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-up Study
Jessica Liu et al.
GASTROENTEROLOGY (2010)
Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
Maurizia Rossana Brunetto et al.
GASTROENTEROLOGY (2010)
Clearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma in a Cohort Chronically Infected with Hepatitis B Virus
Josephine Simonetti et al.
HEPATOLOGY (2010)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
A Longitudinal Study on the Natural History of Serum Hepatitis B Surface Antigen Changes in Chronic Hepatitis B
Henry Lik-Yuen Chan et al.
HEPATOLOGY (2010)
Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline
Milan J. Sonneveld et al.
HEPATOLOGY (2010)
Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers: Disease Phase Influences Correlation with Viral Load and Intrahepatic Hepatitis B Virus Markers
Alexander J. V. Thompson et al.
HEPATOLOGY (2010)
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
Tin Nguyen et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
Jerzy Jaroszewicz et al.
JOURNAL OF HEPATOLOGY (2010)
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
R. G. Gish et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Hepatitis B Virus Surface Antigen Levels: A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B
Maurizia Rossana Brunetto et al.
HEPATOLOGY (2009)
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
Ding-Shinn Chen
JOURNAL OF HEPATOLOGY (2009)
HBsAg seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma
Man-Fung Yuen et al.
GASTROENTEROLOGY (2008)
Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response
Man-Fung Yuen et al.
HEPATOLOGY (2007)
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
MF Yuen et al.
GUT (2005)
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
SH Ahn et al.
JOURNAL OF HEPATOLOGY (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy
MC Kuhns et al.
TRANSFUSION (2004)
Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration
CA Bill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
MF Yuen et al.
HEPATOLOGY (2004)
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study
MR Brunetto et al.
JOURNAL OF HEPATOLOGY (2002)
Share Paper
